“We are in a period of what I’ll call fintech maximalism,” says Chemistry founder and GP Mark Goldberg. “By that, I mean the companies that grew up in the last five to ten years in fintech, those that quietly executed through the winter of the 2021 to 2024 period, have emerged as compounders in a […]
We’ve entered an era of Fintech Maximalism according to Mark Goldberg Read More »
What happens when a chemical engineer, who’s previously built a hydrogen-powered drone, becomes a venture capitalist? Energy Revolution Ventures, that’s what. The VC has now closed an $18 million Seed and Series A fund to invest in deeptech, such as energy storage, carbon capture, and, yes, hydrogen technologies. Marcus Clover, Co-Founder and Partner at ERV
If startup funding rounds are any metric, generative AI is seeing ample adoption in the sciences. It makes sense: there’s a lot of trial and error involved in research and development, and any tool that can speed up the process for researchers is bound to be useful. The latest is Albert Invent, which offers an
Albert Invent hopes to revolutionize the chemicals sector with its AI platform Read More »
For centuries, people chewed willow tree bark to relieve pain, but scientists at chemical firm Bayer didn’t isolate its active ingredient until the 1800s and eventually patented its modified version as Aspirin. Aspirin is just one example of a medicine derived from natural sources. In fact, the World Health Organization estimates that around 40% of
Enveda raises $55M to combine ancient remedies with AI for drug discovery Read More »
